Literature DB >> 6296418

Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells.

B Westermark, A Magnusson, C H Heldin.   

Abstract

Two clones, designated Cl 2 and Cl 3, were established from the human malignant glioma line U-343 MGa. The astrocytic origin of the cells was proven by the presence in virtually 100% of the cells of the astrocyte marker glial fibrillary acidic protein. The addition of 10 ng epidermal growth factor (EGF) per milliliter to Cl 2 and Cl 3 cells resulted in the rapid appearance of large cell surface ruffles, visualized by scanning electron microscopy. A time course study by phase contrast microscopy showed that the maximal ruffling activity occurred 5 minutes after addition of EGF. Under basic culture conditions (Eagle's MEM, 10% fetal calf serum), Cl 2 and Cl 3 cells were essentially immobile and formed tightly packed, well demarcated colonies. In the presence of 10 ng EGF per milliliter, no defined colonies were formed and the cells seemed to move around freely. The stimulatory effect of EGF on cell migration was confirmed by growing the cells on a deposit of colloidal gold; in the absence of EGF, the cells remained immobile whereas cells grown at 10 ng EGF per ml formed long phagokinetic tracks. The effect of EGF on membrane motility and cell locomotion occurred in the absence of any effect of EGF on growth rate; both clones multiplied at the same rate in the absence as in the presence of EGF. Binding experiments using 125I-labeled EGF demonstrated a single class of high affinity receptors. The number of 180,000 receptors per cell was estimated in both clones. The finding that human glioma cells in culture require EGF for their migration raises the interesting possibility that tumor cells in vivo may respond in a similar fashion, and in that case require a growth factor for migration and for the expression of their infiltrative growth potential. Furthermore, the present findings strengthen the notion that glial cells should be recognized as targets for EGF.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6296418     DOI: 10.1002/jnr.490080236

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  35 in total

1.  Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma.

Authors:  A Gabriella Wernicke; Adam P Dicker; Michal Whiton; Jana Ivanidze; Terry Hyslop; Elizabeth H Hammond; Arie Perry; David W Andrews; Lawrence Kenyon
Journal:  Radiat Oncol       Date:  2010-05-30       Impact factor: 3.481

2.  Epithelial cell guidance by self-generated EGF gradients.

Authors:  Cally Scherber; Alexander J Aranyosi; Birte Kulemann; Sarah P Thayer; Mehmet Toner; Othon Iliopoulos; Daniel Irimia
Journal:  Integr Biol (Camb)       Date:  2012-02-08       Impact factor: 2.192

Review 3.  Growth factors in bladder cancer.

Authors:  M Liebert
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

4.  Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines.

Authors:  M H Werner; P A Humphrey; D D Bigner; S H Bigner
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

5.  Aberrations of growth factor control in metastatic follicular thyroid cancer in vitro.

Authors:  T Hoelting; A Zielke; A E Siperstein; O H Clark; Q Y Duh
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

6.  Tumorigenic, invasive, karyotypic, and immunocytochemical characteristics of clonal cell lines derived from a spontaneous canine anaplastic astrocytoma.

Authors:  M E Berens; G Bjotvedt; D C Levesque; M D Rief; J R Shapiro; S W Coons
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-04       Impact factor: 2.416

7.  Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture.

Authors:  M Lund-Johansen; K Forsberg; R Bjerkvig; O D Laerum
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation.

Authors:  Mikael S Lindström; Monica Nistér
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

9.  Quantitative proteomic analysis reveals effects of epidermal growth factor receptor (EGFR) on invasion-promoting proteins secreted by glioblastoma cells.

Authors:  Vineet Sangar; Cory C Funk; Ulrike Kusebauch; David S Campbell; Robert L Moritz; Nathan D Price
Journal:  Mol Cell Proteomics       Date:  2014-07-05       Impact factor: 5.911

10.  Multiscale agent-based cancer modeling.

Authors:  Le Zhang; Zhihui Wang; Jonathan A Sagotsky; Thomas S Deisboeck
Journal:  J Math Biol       Date:  2008-09-12       Impact factor: 2.259

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.